- 专利标题： Prodrugs of hydroxamate-based GCPII inhibitors
-
申请号： US17372899申请日： 2021-07-12
-
公开(公告)号： US11866394B2公开(公告)日： 2024-01-09
- 发明人: Barbara Slusher , Rana Rais , Jan Vavra , Tomas Tichy , Pavel Majer , Andrej Jancarik , Lukas Tenora
- 申请人： The Johns Hopkins University , Institute of Organic Chemistry and Biochemistry AS CR v.v.i.
- 申请人地址： US MD Baltimore
- 专利权人： THE JOHNS HOPKINS UNIVERSTY,INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY AS CR V.V.I.
- 当前专利权人： THE JOHNS HOPKINS UNIVERSTY,INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY AS CR V.V.I.
- 当前专利权人地址： US MD Baltimore; CZ Prague
- 代理机构： Casimir Jones, SC
- 代理商 Jeffrey W. Childers
- 分案原申请号： US16461630
- 主分类号： C07C259/06
- IPC分类号： C07C259/06 ; A61P25/02 ; C07C259/08 ; C07D317/38
摘要：
Prodrugs of hydroxamate-based GCPII inhibitors and methods of their use for treating a disease or condition are disclosed.
公开/授权文献
- US20210355079A1 PRODRUGS OF HYDROXAMATE-BASED GCPII INHIBITORS 公开/授权日：2021-11-18
信息查询
